M&A Deal Summary |
|
|---|---|
| Date | 2020-11-18 |
| Target | Organic Candy Factory |
| Sector | Food |
| Buyer(s) | Vertical Wellness |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2019 |
| Sector | Consumer Products |
Vertical Wellness is a vertically integrated consumer-focused health and wellness brand company with innovative Hemp cannabinoid solutions. The company's mission is to help people by bringing the most innovative and effective portfolio of cannabinoid (CBD and others) brands to the market. Initial VWEL brands include Kathy Ireland Health & Wellness, Taos, Lap Dog, Par5, Halogenix, Wingra Farms, Neutrate, USMCC, and Hemp-Moji. VWEL Services leverages its extensive investment and team knowledge by helping the entire industry with strategic, financial, branding, sales, and hemp processing solutions. Vertical Wellness has operations in California and Kentucky and cultivated over 1,800 acres of hemp on partner farms in 2019.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Food M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2020 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-22 |
Tech-Holdings
New York, United States Tech-Holdings is a technology-focused cannabinoid (CBD and others) research and development company. One of the early R&D investors in cannabinoid ingredient efficacy and delivery methods, Tech-Holdings developed a body of Intellectual Property "IP" around cannabinoid delivery that make products more effective (higher bioavailability) and faster acting. One of the primary advantages of products utilizing the patented delivery system is the rapid diffusion of lipid molecules across the epithelium and into the bloodstream bypassing first-pass liver processing. A second advantage is the increased efficiency of absorption. The limited absorption and diffusion profiles of most of the current products in the market fail to deliver cannabinoids across the epithelium or the upper GI tract. This limits absorption to the intestine, thus subjecting all cannabinoids to first-pass liver processing which may reduce effectiveness. Tech-Holdings technology provides for rapid diffusion both across the epithelium and into the bloodstream to efficiently deliver beneficial molecules. It also enables the production of cannabinoid enriched powders that easily mix with water allowing for the development of fast-acting topicals/targeted cosmetics and a wide variety of edible/consumable products. |
Buy | - |
